1. Home
  2. KORE vs CALC Comparison

KORE vs CALC Comparison

Compare KORE & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORE Group Holdings Inc.

KORE

KORE Group Holdings Inc.

HOLD

Current Price

$4.36

Market Cap

77.5M

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$6.13

Market Cap

91.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KORE
CALC
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.5M
91.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KORE
CALC
Price
$4.36
$6.13
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$14.50
AVG Volume (30 Days)
51.0K
149.0K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$285,408,000.00
N/A
Revenue This Year
$1.26
N/A
Revenue Next Year
$7.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.06
N/A
52 Week Low
$1.30
$1.42
52 Week High
$4.88
$6.40

Technical Indicators

Market Signals
Indicator
KORE
CALC
Relative Strength Index (RSI) 54.55 73.00
Support Level $4.10 $4.64
Resistance Level $4.50 $6.40
Average True Range (ATR) 0.26 0.50
MACD -0.02 0.14
Stochastic Oscillator 58.33 84.85

Price Performance

Historical Comparison
KORE
CALC

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: